Natalie Johnston

Natalie Johnston is an Investment Principal at 4BIO Capital, an early-stage life sciences investment firm based in London, UK. Before entering the venture capital industry, she earned a PhD in biomedical research from Imperial College London, where her academic studies focused on applying optogenetic techniques to the pancreas. In her current role, Johnston evaluates and executes early-stage transactions across the advanced therapies sector, targeting novel gene therapies and treatments for chronic diseases. Operating within 4BIO Capital, she collaborates with a specialized team that includes foundational figures in the gene therapy field and researchers from global centers of clinical excellence. This allows her to analyze complex biological mechanisms and identify biotechnology startups for the firm's portfolio. Ultimately, Johnston leverages her specialized academic training to drive strategic capital allocation toward the commercialization of next-generation genetic medicines.